These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 22427128)

  • 1. The effects of 5-HT4 receptor agonist, mosapride citrate, on visceral hypersensitivity in a rat model.
    Lee JW; Sung KW; Lee OY; Lee SE; Sohn CI
    Dig Dis Sci; 2012 Jun; 57(6):1517-24. PubMed ID: 22427128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of mosapride citrate, a 5-HT4-receptor agonist, on gastric distension-induced visceromotor response in conscious rats.
    Seto Y; Yoshida N; Kaneko H
    J Pharmacol Sci; 2011; 116(1):47-53. PubMed ID: 21521930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of 5-HT4 receptor agonist mosapride citrate on rectosigmoid sensorimotor function in patients with irritable bowel syndrome.
    Kanazawa M; Watanabe S; Tana C; Komuro H; Aoki M; Fukudo S
    Neurogastroenterol Motil; 2011 Aug; 23(8):754-e332. PubMed ID: 21615623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of effect of mosapride citrate and existing 5-HT4 receptor agonists on gastrointestinal motility in vivo and in vitro.
    Mine Y; Yoshikawa T; Oku S; Nagai R; Yoshida N; Hosoki K
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1000-8. PubMed ID: 9399969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DSP-6952, a novel 5-HT
    Mine Y; Itakura T; Oku S; Asada R; Shimizu I
    Eur J Pharmacol; 2018 May; 826():123-132. PubMed ID: 29428470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-emetic effect of mosapride citrate hydrate, a 5-HT4 receptor agonist, on selective serotonin reuptake inhibitors (SSRIs)-induced emesis in experimental animals.
    Mine Y; Oku S; Yoshida N
    J Pharmacol Sci; 2013; 121(1):58-66. PubMed ID: 23257657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visceral analgesic effect of 5-HT(4) receptor agonist in rats involves the rostroventral medulla (RVM).
    Sengupta JN; Mickle A; Kannampalli P; Spruell R; McRorie J; Shaker R; Miranda A
    Neuropharmacology; 2014 Apr; 79():345-58. PubMed ID: 24334068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 5-HT4 receptor agonist mosapride attenuates inflammation of reflux esophagitis.
    Zhuang ZH; Zou FM; Tang DP; Zhuang JY; Wei JJ; Yang LY
    Hepatogastroenterology; 2014; 61(129):115-9. PubMed ID: 24895805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual role of mosapride citrate hydrate on the gastric emptying evaluated by the breath test in conscious rats.
    Uchida M; Yamato S; Shimizu K; Amano T; Ariga H
    J Pharmacol Sci; 2013; 121(4):282-7. PubMed ID: 23514789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of a new 5-HT4 receptor partial agonist, YKP10811, on visceral hypersensitivity in rats triggered by stress and inflammation.
    Gilet M; Eutamene H; Han H; Kim HW; Bueno L
    Neurogastroenterol Motil; 2014 Dec; 26(12):1761-70. PubMed ID: 25316608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opposing effects of 5-HT1A receptor agonist buspirone on supraspinal abdominal pain transmission in normal and visceral hypersensitive rats.
    Lyubashina OA; Sivachenko IB; Sushkevich BM; Busygina II
    J Neurosci Res; 2023 Oct; 101(10):1555-1571. PubMed ID: 37331003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of gastric acid on gastric emptying and gastric distension-induced pain response in rats--effects of famotidine and mosapride.
    Keto Y; Hirata T; Takemoto Y; Yamano M; Yokoyama T
    Neurogastroenterol Motil; 2012 Feb; 24(2):147-53, e88. PubMed ID: 22066725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serotonin 5- HT4 receptor agonist (mosapride citrate)].
    Odaka T; Suzuki T; Seza A; Yamaguchi T; Saisho H
    Nihon Rinsho; 2006 Aug; 64(8):1491-4. PubMed ID: 16898619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of colonic mucosal 5-HT(4) receptors accelerates propulsive motility and inhibits visceral hypersensitivity.
    Hoffman JM; Tyler K; MacEachern SJ; Balemba OB; Johnson AC; Brooks EM; Zhao H; Swain GM; Moses PL; Galligan JJ; Sharkey KA; Greenwood-Van Meerveld B; Mawe GM
    Gastroenterology; 2012 Apr; 142(4):844-854.e4. PubMed ID: 22226658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of 5-hydroxytryptamine receptor 4 agonist mosapride on human gastric accommodation.
    Amano T; Ariga H; Kurematsu A; Yamato S; Morioka S; Masaka A; Kanazawa M; Fukudo S
    Neurogastroenterol Motil; 2015 Sep; 27(9):1303-9. PubMed ID: 26303048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of mosapride citrate on gastric motility and autonomic nervous function: evaluation by spectral analyses of heart rate and blood pressure variabilities, and by electrogastrography.
    Endo J; Nomura M; Morishita S; Uemura N; Inoue S; Kishi S; Kawaguchi R; Iga A; Ito S; Nakaya Y
    J Gastroenterol; 2002; 37(11):888-95. PubMed ID: 12483243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antinociceptive effect of intravenous imipramine in colorectal distension-induced visceral pain in rats: the role of serotonergic and noradrenergic receptors.
    İlkaya F; Bilge SS; Bozkurt A; Baş DB; Erdal A; Çiftçioğlu E; Kesim Y
    Pharmacol Biochem Behav; 2014 Jul; 122():1-6. PubMed ID: 24582849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of mosapride citrate in proximal gastric accommodation and gastrointestinal motility in healthy volunteers: a double-blind placebo-controlled ultrasonographic study.
    Kusunoki H; Haruma K; Hata J; Kamada T; Ishii M; Yamashita N; Inoue K; Imamura H; Manabe N; Shiotani A
    J Gastroenterol; 2010 Dec; 45(12):1228-34. PubMed ID: 20658155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of mosapride citrate, a 5-HT4 receptor agonist, on colonic motility in conscious guinea pigs.
    Inui A; Yoshikawa T; Nagai R; Yoshida N; Ito T
    Jpn J Pharmacol; 2002 Dec; 90(4):313-20. PubMed ID: 12501007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacological effects of the gastroprokinetic agent mosapride citrate].
    Yoshida N
    Nihon Yakurigaku Zasshi; 1999 May; 113(5):299-307. PubMed ID: 10480157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.